COMMUNIQUÉS West-GlobeNewswire

Oculis Reports Q1 2026 Financial Results and Provides Company Update
11/05/2026
ZUG, Switzerland, May 11, 2026 (GLOBE NEWSWIRE) -- Pipeline Advancing as Planned, Leading with OCS-01 Key Milestone Completion of LPLV in Both DIAMOND Phase 3 Trials; Data Readout on Track for June 2026 Licaminlimab [...]
Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update
11/05/2026
Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant prostate cancer (mCRPC) is progressing well with the interim analysis [...]
Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates
11/05/2026
Announced strategic collaboration with Mayo Clinic, focused on improving care in type 1 diabetes and accelerating development of SC451 Continued progress toward starting SC451 Phase 1 trial later this year, including [...]
Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026
11/05/2026
Announced two-trial clinical development strategy for AKY-2519 enabling evaluation in multiple patient segments Initiated Phase 1b clinical trial of AKY-2519 in metastatic castration-resistant prostate cancer (mCRPC); [...]
Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights
11/05/2026
Phase 3 CoMpass trial advancing toward enrollment completion, supporting 2H 2027 topline data Natalie Holles appointed Chief Executive Officer and President and member of the Board of Directors Strengthened balance [...]
STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year
11/05/2026
Full year fiscal 2026 revenue from continuing operations increased 9%; constant currency organic revenue growth was 7% Full year fiscal 2026 as reported diluted EPS from continuing operations increased to $7.93; [...]
Abivax Announces Results of its May 11, 2026 Annual General Meeting
11/05/2026
Abivax Announces Results of its May 11, 2026 Annual General Meeting PARIS, France – May 11, 2026 – 10:05 pm CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical- [...]
Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026
11/05/2026
DURHAM, N.C., May 11, 2026 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT ) today announced that it will report its financial results for the fourth quarter and fiscal year ended March 31, 2026, and provide a business [...]
LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
11/05/2026
Q1 2026 total revenue of $1.9 million, including $1.7 million in VIZZ ® product sales Approximately 46,000 paid prescriptions filled and over 10,000 prescribing eye care professionals from launch through Q1 2026 [...]
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
11/05/2026
Net Revenue Growth of 19% and Net Profitability from Continuing Operations of $0.04 Per Fully Diluted Share for the Quarter FORT WORTH, TX, May 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” “Sanara MedTech [...]
Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights
11/05/2026
In the first full quarter since launch, 2,145 healthcare providers prescribed TONMYA ® , 3,588 patients initiated treatment, and ~5,400 prescriptions were filled Agreement signed in May with leading group purchasing [...]
Sangamo Therapeutics Announces First Quarter 2026 Earnings Call
11/05/2026
RICHMOND, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (OTCQB Venture Market: SGMO), a genomic medicine company today announced that the company has scheduled the release of its first quarter 2026 [...]
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provide Business Update on Wednesday, May 20, 2026
11/05/2026
BASEL, Switzerland and LONDON and NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Wednesday, May 20, 2026, to [...]
CORRECTION – Human Appeal Launches Hajj Step Challenge, Turning Steps into a Lifeline
11/05/2026
Participants challenged to walk 10,000 steps a day during the 10 most sacred days of the Islamic Calendar, raising funds to deliver vital meals to those in need In a release issued earlier on Monday, May 11, under the [...]
FDA Advances Drug Repurposing to Address Unmet Medical Needs
11/05/2026
Agency is particularly focused on new uses to treat chronic or rare diseases White Oak, Md., May 11, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced it is soliciting input on efforts with [...]
Sotera Health Announces Secondary Offering of Common Stock
11/05/2026
CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 31,838,253 shares of its common stock, par value $0. [...]
Cellectis publie ses résultats financiers du premier trimestre 2026
11/05/2026
Phase 2 pivot évaluant lasmé-cel dans la LAL-B en rechute ou réfractaire (étude BALLI-01) Analyse intermédiaire de phase 2 pivot attendue en Q4 2026 Dépôt de demande d'autorisation de mise sur le marché (BLA) prévu en [...]
SCYNEXIS Reports First Quarter 2026 Financial Results and Provides Corporate Update
11/05/2026
Completed transformative acquisition of PXL-770, (now SCY-770), an innovative, highly selective, direct AMPK activator for the treatment of autosomal dominant polycystic kidney disease (ADPKD) A Phase 2 proof-of-concept [...]
Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates
11/05/2026
In the ongoing Phase 2 AMPLIFY-7P study evaluating ELI-002 7P in patients with pancreatic ductal adenocarcinoma (“PDAC”), the event-driven primary disease-free survival (“DFS”) analysis is anticipated mid-year 2026 The [...]

Pages